Your browser doesn't support javascript.
loading
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort.
Finkelmeier, Fabian; Scheiner, Bernhard; Leyh, Catherine; Best, Jan; Fründt, Thorben Wilhelm; Czauderna, Carolin; Beutel, Alica; Bettinger, Dominik; Weiß, Johannes; Meischl, Tobias; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Radu, Pompilia; Schultheiß, Michael; Peiffer, Kai-Henrik; Ettrich, Thomas J; Weinmann, Arndt; Wege, Henning; Venerito, Marino; Dufour, Jean-Francois; Lange, Christian M; Pinter, Matthias; Waidmann, Oliver.
Afiliação
  • Finkelmeier F; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
  • Scheiner B; University Cancer Center Frankfurt, University Hospital Frankfurt, Frankfurt, Germany.
  • Leyh C; Frankfurt Cancer Institute, Goethe University Frankfurt/Main, Frankfurt, Germany.
  • Best J; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Fründt TW; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Czauderna C; Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany.
  • Beutel A; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-Von Guericke University Hospital, Magdeburg, Germany.
  • Bettinger D; Department of Medicine, Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Weiß J; Department of Internal Medicine 1, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Meischl T; Clinical Registry Unit (CRU), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Kütting F; Department of Medicine I, University Medical Center Schleswig Holstein-Campus Lübeck, Lübeck, Germany.
  • Waldschmidt DT; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
  • Radu P; Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schultheiß M; Berta Ottenstein Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Peiffer KH; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Ettrich TJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Weinmann A; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Wege H; Department of Gastroenterology and Hepatology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Venerito M; Department of Gastroenterology and Hepatology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Dufour JF; Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Lange CM; Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Pinter M; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
  • Waidmann O; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Liver Cancer ; 10(4): 360-369, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34414123
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article